Gene transfer technologies for malignant gliomas - PubMed (original) (raw)
Review
Gene transfer technologies for malignant gliomas
A Weyerbrock et al. Curr Opin Oncol. 1999 May.
Abstract
Although early clinical gene therapy trials for recurrent central nervous system neoplasms showed the proof-of-principle, they did not fulfill the high expectations suggested by the preclinical experimental data. Insufficient distribution of vectors in human brain tumors and very low transduction efficiency require that we reevaluate gene transfer concepts for brain tumor treatment. Major steps to improve gene transfer into the central nervous system and the efficacy of gene therapy for malignant brain tumors include: 1) the design of more effective vector systems; 2) the development of new or improved prodrug/suicide systems, gene replacement approaches, or strategies targeting the immune response or tumor angiogenesis; 3) the study of new techniques to enhance delivery of genetic vectors into brain tumors and for monitoring gene delivery into tumors; and 4) assessment of the role of gene therapy as part of a combined treatment approach.
Similar articles
- Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
Harada H, Nakagawa K, Iwata S, Saito M, Kumon Y, Sakaki S, Sato K, Hamada K. Harada H, et al. Cancer Res. 1999 Aug 1;59(15):3783-9. Cancer Res. 1999. PMID: 10446996 - Regulation of angiogenesis in malignant gliomas.
Guerin C, Laterra J. Guerin C, et al. EXS. 1997;79:47-64. doi: 10.1007/978-3-0348-9006-9_4. EXS. 1997. PMID: 9002220 Review. - Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.
Im SA, Gomez-Manzano C, Fueyo J, Liu TJ, Ke LD, Kim JS, Lee HY, Steck PA, Kyritsis AP, Yung WK. Im SA, et al. Cancer Res. 1999 Feb 15;59(4):895-900. Cancer Res. 1999. PMID: 10029081 - Angiogenesis by gene therapy: a new horizon for myocardial revascularization?
Lewis BS, Flugelman MY, Weisz A, Keren-Tal I, Schaper W. Lewis BS, et al. Cardiovasc Res. 1997 Sep;35(3):490-7. doi: 10.1016/s0008-6363(97)00170-3. Cardiovasc Res. 1997. PMID: 9415293 Review.
Cited by
- Uptake, cellular distribution and novel cellular binding proteins of immunostimulatory CpG oligodeoxynucleotides in glioblastoma cells.
Zhang Z, Weinschenk T, Schluesener HJ. Zhang Z, et al. Mol Cell Biochem. 2005 Apr;272(1-2):35-46. doi: 10.1007/s11010-005-6605-0. Mol Cell Biochem. 2005. PMID: 16010970 - Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors.
Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, di Tomaso E, Brown EB, Izumi Y, Campbell RB, Berk DA, Jain RK. Pluen A, et al. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4628-33. doi: 10.1073/pnas.081626898. Epub 2001 Mar 27. Proc Natl Acad Sci U S A. 2001. PMID: 11274375 Free PMC article. - Glioblastoma multiforme: the terminator.
Holland EC. Holland EC. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6242-4. doi: 10.1073/pnas.97.12.6242. Proc Natl Acad Sci U S A. 2000. PMID: 10841526 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical